Jason P Rhodes Insider Trading Activity

Corporate InsiderDirector · CIK 1577014

57

Total trades

$35.3M

Total volume

Jun 25, 2026

Last activity

DYN

Dyne Therapeutics, Inc.

Jason P Rhodes has been net-selling over the last 12 months with 0 purchases and 57 sales across 1 company.

DYN is the most-traded position with 57 trades. The largest single transaction was a sale of DYN for $3.0M on Apr 22, 2026.

Performance Scorecard

Forward stock performance after each transaction by Jason P Rhodes. Buy returns measure price movement after open-market purchases; sell-avoided measures the loss avoided after open-market sales. Success rate counts trades where the insider's direction was right.

PERIODAVG BUY RETURNAVG SELL AVOIDEDSUCCESS RATETRADES
30 days+2.5%67%54
90 days-20.9%0%24
120 days

Performance based on stock price movement after each transaction date. Past results do not predict future returns. Not financial advice.

Price & Trades

Pro: Trade Markers

DYN · Dyne Therapeutics, Inc.

🔒 Subscribe to see trade entries

Pro members see exactly when Jason P Rhodes bought and sold DYN.

Upgrade to Pro

Recent Trades

Showing the 50 most recent of 57 disclosed trades.

DATETICKERTYPESHARESPRICEVALUEΔ OWNEDROLEFILING
Jun 25, 2026
DYNSell5,019$21.10$106K−0.5%Director
Jun 25, 2026
DYNSell12,699$21.10$268K−0.3%Director
Jun 25, 2026
DYNSell6,382$21.10$135K−0.4%Director
Jun 24, 2026
DYNSell50,530$21.02$1.1M−1.1%Director
Jun 24, 2026
DYNSell19,973$21.02$420K−1.8%Director
Jun 24, 2026
DYNSell25,397$21.02$534K−1.7%Director
Jun 23, 2026
Filed 3d late
DYNSell30,774$21.13$650K−2.7%Director
Jun 23, 2026
Filed 3d late
DYNSell39,131$21.13$827K−2.5%Director
Jun 23, 2026
Filed 3d late
DYNSell77,855$21.13$1.6M−1.6%Director
May 6, 2026
DYNSell17,244$18.18$313K−1.5%Director
May 6, 2026
DYNSell43,621$18.18$793K−0.9%Director
May 6, 2026
DYNSell21,926$18.18$399K−1.4%Director
May 6, 2026
DYNSell428$18.18$8K−5.1%Director
May 5, 2026
DYNSell6,081$18.03$110K−0.1%Director
May 5, 2026
DYNSell2,403$18.03$43K−0.2%Director
May 5, 2026
DYNSell3,056$18.03$55K−0.2%Director
May 5, 2026
DYNSell60$18.03$1K−0.7%Director
May 4, 2026
DYNSell3,136$18.00$56K−0.2%Director
May 4, 2026
DYNSell6,241$18.00$112K−0.1%Director
May 4, 2026
DYNSell61$18.00$1K−0.7%Director
May 4, 2026
DYNSell2,466$18.00$44K−0.2%Director
Apr 28, 2026
DYNSell52$19.00$988−0.0%Director
Apr 28, 2026
DYNSell1$19.00$19−0.0%Director
Apr 28, 2026
DYNSell21$19.00$399−0.0%Director
Apr 28, 2026
DYNSell59,870$18.38$1.1M−3.7%Director
Apr 28, 2026
DYNSell119,115$18.38$2.2M−2.4%Director
Apr 28, 2026
DYNSell1,170$18.38$22K−12.1%Director
Apr 28, 2026
DYNSell47,082$18.38$865K−3.9%Director
Apr 28, 2026
DYNSell26$19.00$494−0.0%Director
Apr 27, 2026
DYNSell90,943$18.15$1.7M−1.8%Director
Apr 27, 2026
DYNSell894$18.15$16K−8.5%Director
Apr 27, 2026
DYNSell35,947$18.15$652K−2.9%Director
Apr 27, 2026
DYNSell45,709$18.15$830K−2.7%Director
Apr 24, 2026
DYNSell72,310$18.48$1.3M−1.4%Director
Apr 24, 2026
DYNSell710$18.48$13K−6.3%Director
Apr 24, 2026
DYNSell28,583$18.48$528K−2.2%Director
Apr 24, 2026
DYNSell36,345$18.48$672K−2.1%Director
Apr 23, 2026
DYNSell38,322$19.19$735K−0.7%Director
Apr 23, 2026
DYNSell377$19.19$7K−3.2%Director
Apr 23, 2026
DYNSell15,148$19.19$291K−1.2%Director
Apr 23, 2026
DYNSell19,261$19.19$370K−1.1%Director
Apr 22, 2026
DYNSell150,942$19.68$3.0M−2.8%Director
Apr 22, 2026
DYNSell1,485$19.68$29K−11.3%Director
Apr 22, 2026
DYNSell59,663$19.68$1.2M−4.4%Director
Apr 22, 2026
DYNSell75,866$19.68$1.5M−4.2%Director
Apr 21, 2026
DYNSell769$20.05$15K−0.0%Director
Apr 21, 2026
DYNSell15$20.05$300.75−0.1%Director
Apr 21, 2026
DYNSell605$20.05$12K−0.0%Director
Apr 21, 2026
DYNSell1,398$19.51$27K−9.6%Director
Apr 21, 2026
DYNSell142,253$19.51$2.8M−2.6%Director

Top Companies Traded

TICKERCOMPANYTRADESTOTAL VOLUME
DYNDyne Therapeutics, Inc.57$35.3M

Other insiders at Dyne Therapeutics, Inc.

5 other tracked filers at DYN.